By Jessica Hamzelou The baby baboon is wearing a mesh gown and appears to be sitting upright. “This little lady … looks pretty philosophical, I would say,” says Eli Katz, who is showing me the image over a Zoom call. This baboon is the first to receive a heart transplant from a young gene-edited pig as part of a study that should pave the way for similar transplants in human babies, says Katz, chief medical officer at the biotech company
Related Posts
PharmEasy has skipped the growth pill for profitability. This may lead to side effects
Healthtech company PharmEasy seems to finally be able to hold its head above water. The unicorn, which has been struggling…
Cipla in talks for a private-equity deal? Here’s what could be on the mind of founder Yusuf Hamied.
Friends, I represent the Third World. I represent the needs and aspirations of the Third World. I represent the capabilities…
Bravo Pharma officially partners with G42 Healthcare to spearhead the field of Genomics
World-leading healthcare specialists Bravo Pharma have officially entered a strategic partnership with the region’s pioneering AI-powered healthcare company G42 Healthcare.…
